The contribution of a Drug Information Center to improve safety in the drug chain
DOI:
https://doi.org/10.30968/rbfhss.2023.143.0978Abstract
Objective: To describe the contribution of the CIM of the Federal University of Ceará (CIM/UFC) in promoting the safe use of the drug chain, through the analysis of passive information stored by the service. Method: A retrospective cross-sectional study was carried out to identify the profile of requests for information. 100% of the information requests (SI) made to the CIM/UFC, from January 2009 to December 2022, were used. Descriptive statistics were used to present the data. Results: 916 requests were received during the 14 years observed by the study, 70.85% of the requesters were female, 55.24% had completed higher education, 58.73% were non-users of the drugs involved, 59.72% were pharmacists, and 19.65% worked in the hospital environment. Medications according to therapeutic subgroups were: psychoanaleptics (n=87; 6.99%), antibacterials for systemic use (n=82; 6.59%), psycholeptics (n=68; 5.46%). The most frequent questions were: drug interactions (n = 13.76%), adverse reactions (12.30%), administration scheme (10.09%), indication (8.83%) and stability (7.57%). Databases were used as sources for response in 50.82% of information requests. Conclusion: The CIM/UFC has contributed, over the years, in a relevant way by providing quality information to its users, notably pharmaceutical professionals who work in the hospital environment, subsidizing these professionals in their practice, contributing to rational prescription and safety of the drug chain. Faced with the reduction in the number of requests made to the CIM/UFC, an alternative for the sustainability of the service is to invest in the production of informative material.
Downloads
References
Behera SK, Xavier AS, Gunaseelan V, et al. Drug information center as referral service in a South Indian tertiary care hospital. International Journal of Pharmaceutical Investigation, 2017; 7(4): 182-187. DOI: 10.4103/jphi.JPHI_90_17.
Santos JRB. Regional drug information center disseminates educational materials related to the COVID-19 pandemic. Exploratory research in clinical and social pharmacy. 2021; 4, 100080. DOI: 10.1016/j.rcsop.2021.100080.
World Health Organization. The pursuit of responsible use of medicines: sharing and learning from country experiences. Amsterdam: WHO (2012). Available in: https://apps.who.int/iris/bitstream/handle/10665/75828/WHO?sequence=1.201. Accessed on: 5st Jan 2022.
Conselho Federal de Farmácia. Centro Brasileiro de Informação sobre Medicamentos (Cebrim/CFF). Available in: https://www.cff.org.br/pagina.php?id=213&menu=&titulo=Outros+-CIM+no+Brasil. Accessed on: 28 Mai 2023.
Vilela RPB, Pompeo DA, Jericó MA, et al. Custo do erro de medicação e eventos adversos à medicação na cadeia medicamentosa: uma revisão integrativa.J. Bras Econ Saúde. 2018;10(2): 179-189. DOI: 10.21115/JBES.v10.n2.p179-189.
World Health Organization. Global Patient Safety Challenge. Medication without harm. 2017. Available in: http://apps.who.int/iris/bitstream/handle/10665/255263/WHO-HIS-SDS-2017.6-eng.pdf?sequence=1. Accessed on: 5st Jan 2022.
Challenge, WHO Global Patient Safety. Medication without harm. World Health Organization, 2017. Licence: CC BY-NC-SA 3.0 IGO. Available in: https://www.who.int/initiatives/medication-without-harm. Accessed on: 5st Jan 2022.
Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde. Departamento de Assistência Farmacêutica e Insumos Estratégicos. Centros e Serviços de Informação sobre Medicamentos: princípios, organização, prática e trabalho em redes para promoção do Uso Racional de Medicamentos [recurso eletrônico] / Ministério da Saúde, Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde, Departamento de Assistência Farmacêutica e Insumos Estratégicos. Brasília: Ministério da Saúde, 2020. 251 p. : il.
Coêlho HLL, Arrais PSD. Desenvolvimento da farmacoepidemiologia no Brasil: I Seminário Brasileiro de Farmacoepidemiologia. Cadernos de Saúde Pública, 1999;15(1): 204-204. DOI: 10.1590/S0102-311X1999000100021.
Simón A, Mendes AP. Os Centros de Informação de Medicamentos: Evolução e Perspetivas Futuras a Partir da Experiência de um Centro Nacional. Revista Portuguesa de Farmacoterapia. 2018;10(4):20-29. DOI: 10.25756/rpf.v10i4.200.
Moretti FA, Oliveira VE, Silva EMK. Acesso a informações de saúde na internet: uma questão de saúde pública?. Revista da Associação Médica Brasileira. 2012; 58(6): 650-658. DOI: 10.1590/S0104-42302012000600008.
Paim NA, Gnatta D. Drug Purchases’s analysis for COVID-19 treatment in Rio Grande do Sul. Rev Bras Farm Hosp Serv Saúde. 2021;12(2):0554. DOI: 10.30968/rbfhss.2021.122.0554.
Entezari-Maleki T, Taraz M, Javadi MR, et al. A two-year utilization of the pharmacist-operated drug information center in Iran. Journal of Research in Pharmacy Practice. 2014;3(4):117-122. DOI: 10.4103/2279-042X.145368.
Almuqbil M, Alrojaie L, Alturki H, et al. The role of drug information centers to improve medication safety in Saudi Arabia-a study from healthcare professionals’ perspective. Saudi Pharmaceutical Journal. 2022;30(4):377-381. DOI: 10.1016/j.jsps.2022.01.024.
Aguiar G, Moreira GJS, Passos ACB, et al. Conhecimento e grau de satisfação dos farmacêuticos usuários de um Centro de Informação Sobre Medicamentos (CIM). Revista Brasileira em Promoção da Saúde. 2005;18(4): 185-190. DOI: 10.5020/18061230.2005.p185.
Ashenef A, Reshid E, Yilma Z, et al. Assessment of the use and status of new drug information centers in a developing country, Ethiopia: the case of public university hospital drug information centers. BioMed Research International. 2018. DOI: 10.1155/2018/3840976.
Estigarribia G, Aguilar G, Nuñez ST, et al. Uso de antibióticos en el hospital general del Departamento de San Pedro-Paraguay. Medicina clínica y social. 2020; 4(2):60-67. DOI: 10.52379/mcs.v4i2.142.
Leite JMS, Rocha BP, Moura AKO, et al. Potências de reações adversas e interações medicamentosas relacionadas ao uso de antibióticos em ambiente hospitalar. Journal of Biology & Pharmacy and Agricultural Management. 2020; 16(2):177-195.
Melo CS, Wirowski, N, Oliveira MP. Avaliação da saúde mental e do consumo de antidepressivos e ansiolíticos em adultos jovens durante a pandemia da COVID-19 no Brasil. Research, Society and Development. 2022; 11(7):1-11. DOI: 10.33448/rsd-v11i7.30095.
Heck J, Stichtenoth DO, Sabau R, et al. Clinical-pharmacological drug information center of Hannover Medical School: experiences and analysis from a tertiary care university hospital. Scientific Reports. 2022;12(1):19409. DOI: 10.1038/s41598-022-24005-y.
Maia AG, Batista AM. Perfil de solicitações ao Serviço de Informação sobre Medicamentos (SIM) de um hospital materno-infantil do seridó ocidental potiguar, Brasil. 2020;32(2):153-159. DOI: 10.14450/2318-9312.v32.e2.a2020.pp153-159.
World Health Organization. Global patient safety action plan 2021–2030: towards eliminating avoidable harm in health care. Available in: https://www.who.int/publications/i/item/9789240032705. World Health Organization. 2021. Accessed on: 5 Jan 2022.
EBSCO Information Services (EBSCO). Available in: https://www.ebsco.com/e/pt-br/comunicados-de-imprensa-1/comunicados-de-imprensa/dynamed-and-micromedex-with--watson-e-agora-dynamedex. Accessed on: 26 Mai 2023.
Ashenef A, Reshid E, Yilma Z, et al. Assessment of the use and status of new drug information centers in a developing country, Ethiopia: the case of public university hospital drug information centers. BioMed research international, 2018. DOI: 10.1155/2018/3840976.
World Health Organization. The rational use of drugs. Report of the Conference of Experts Nairobi. Geneva: WHO, 1985.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors hereby transfer, assign, or otherwise convey to RBFHSS: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print republish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to RHFHSS with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Serlf-archiving policy
This journal permits and encourages authors to post and archive the final pdf of the articles submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.
